Observational study of chemotherapy in thymic cancer patients.

Observational study of chemotherapy in thymic cancer patients. - NEJ023

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015649

Enrollment

200

Registered

2014-11-11

Start date

2014-11-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thymic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients with histologically confirmed thymic cancer. 2.Patients who were difficult to treat with radical surgery or radical radiation therapy at diagnosis. 3.Patients who were received 1st line chemotherapy between 01/04/1995 and 31/03/2014.

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

Measure	Time frame
Overall survival (OS)	—

Secondary

Measure	Time frame
OS from the initiation of 2nd line chemotherapy, OS from the initiation of 3rd line chemotherapy, treatment duration, response rate, progression free survival	—

Countries

Japan

Contacts

Public ContactRyo Ko Takehito Shukuya

Juntendo University Department of Respiratory Medicine

rkou@juntendo.ac.jp03-5802-1062

Outcome results